NEW YORK (GenomeWeb News) – Bioinformatics firm Advaita said this week that it has been awarded up to $2.0 million by the National Institutes of Health to develop software for analyzing next-generation sequencing data for personalized medicine applications.

Advaita was awarded a Fast Track Small Business Investigation Research Phase I and II grant by the National Institute of General Medical Sciences to develop advanced software that leverages the Plymouth, Michigan-based firm's pathway analysis software called Pathway-Guide.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.

May
28
Sponsored by
PerkinElmer

This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease.